Horizon Investments’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.75M Sell
47,454
-15,111
-24% -$1.28M 0.04% 363
2026
Q1
$5.39M Sell
62,565
-3,316
-5% -$298K 0.06% 277
2025
Q4
$5.75M Buy
+65,881
New +$5M 0.07% 227
2025
Q3
Sell
-6,412
Closed -$378K 1233
2025
Q2
$378K Buy
6,412
+6,391
+30,433% +$413K 0.01% 843
2025
Q1
$1.54K Hold
21
﹤0.01% 749
2024
Q4
$1.74K Buy
+21
New +$1.66K ﹤0.01% 743

Other funds holding GMED

Horizon Investments's GMED Position: Q2 2026 in Review

Horizon Investments reduced its Globus Medical (GMED) stake by 24% in Q2 2026, selling an estimated $1.28M and leaving 47,454 shares worth $3.75M. The position accounts for 0.04% of the portfolio, ranked #363.

Horizon Investments first reported a position in GMED in Q4 2024 and has held it in 6 quarters since. The position peaked at $5.75M in Q4 2025. 596 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • Horizon Investments held 47,454 shares of Globus Medical worth $3.75M as of Q2 2026.
  • Horizon Investments sold 15,111 Globus Medical shares in Q2 2026, an estimated $1.28M.
  • Globus Medical made up 0.04% of Horizon Investments's portfolio in Q2 2026, its #363 holding.
  • Horizon Investments first reported a position in Globus Medical in Q4 2024 and has held it in 6 quarters since.
  • Horizon Investments's Globus Medical position peaked at $5.75M in Q4 2025.
  • 596 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Horizon Investments's 13F filing for Q2 2026, filed 13 Aug 2026.